Cancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in melanoma.
Ontology highlight
ABSTRACT: One of the major reasons for poor cancer outcomes is the existence of cancer stem cells (CSCs). CSCs are a small subpopulation of tumor cells that can self-renew, differentiate into the majority of tumor cells, and maintain tumorigenicity. As CSCs are resistant to traditional chemotherapy and radiation, they contribute to metastasis and relapse. Thus, new approaches are needed to target and eliminate CSCs. Here, we sought to target and reduce the frequency of CSCs in melanoma by therapeutic vaccination against CSC-associated transcription factors, such as Sox2 and Nanog, and aldehyde dehydrogenase (ALDH). Toward this goal, we have identified novel immunogenic peptide epitopes derived from CSC-associated Sox2 and Nanog and synthesized synthetic high-density lipoprotein (sHDL) nanodisc vacci
SUBMITTER: Aikins ME
PROVIDER: S-EPMC9765445 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA